Hims & Hers semaglutide: November 2026 price and position
As of November 20, 2026, Hims & Hers is a brand route for semaglutide: its page refused automated reads on November 20, 2026 (HTTP 403); Lilly's November 6, 2026 release says Hims patients can buy Zepbound from $299 and Foundayo from $149 at Lilly's self-pay prices, with no Hims fee stated. It sells or prescribes brand medication rather than compounded semaglutide, so it has no place in this site’s compounded semaglutide comparison.
Released · Last reviewed · how we verify
Brand prices for comparison
Bought direct, Zepbound vials cost $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5–15 mg when each refill is within 45 days (otherwise $499 at 7.5 mg and $699 at 10–15 mg); Wegovy pens cost $349 a month and the Wegovy pill $149 to $299 by dose (NovoCare, read November 20, 2026; the Zepbound ladder is carried from October 15 because lilly.com refused automated reads). See the brand price page.
FDA warning letters
FDA’s warning-letter index lists warning letter 716567 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) and warning letter 716825 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) to Hims & Hers; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.
Limitations and what to check before you enroll
Brand Wegovy is FDA-approved. Through Hims & Hers you pay the manufacturer’s self-pay price, or your insurance copay, plus any fee Hims & Hers charges for its own service. Ask for that fee, what it includes and how it renews before you start. A clinician decides whether any GLP-1 is right for you.
Frequently asked
How much does Hims & Hers charge for semaglutide?
As of November 20, 2026, Hims & Hers is a brand route for semaglutide: its page refused automated reads on November 20, 2026 (HTTP 403); Lilly's November 6, 2026 release says Hims patients can buy Zepbound from $299 and Foundayo from $149 at Lilly's self-pay prices, with no Hims fee stated. It sells or prescribes brand medication rather than compounded semaglutide, so it has no place in this site’s compounded semaglutide comparison.
Is Hims & Hers’s semaglutide FDA-approved?
Hims & Hers is a brand route: the brand medication it offers (Wegovy) is FDA-approved. Compounded semaglutide from other programs is not FDA-approved and is not the same product.
Where do these Hims & Hers figures come from?
From Hims & Hers’s own page (not readable Nov 20, November 20, 2026), converted to an all-in month-to-month figure (medication plus any required recurring fee, before tax). The source link and read date are listed below, and the same figures are in the open dataset.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- Federal Register 91 FR 23431: proposed 503B bulks-list decision for semaglutide, tirzepatide and liraglutide (May 1, 2026; no final notice found as of November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- Wegovy (semaglutide) prescribing information on DailyMed (read November 20, 2026)
- Lilly and Hims & Hers joint release (November 6, 2026; read November 20, 2026)
- Hims & Hers Form 10-Q for the quarter ended September 30, 2026 (SEC) (filed November 9, 2026; read November 20, 2026)
- Hims & Hers pricing page (not readable on November 20, 2026)
- FDA warning letter 716567 to Hims & Hers (dated 2025-09-09, posted 2025-09-16; read November 20, 2026)
- FDA warning letter 716825 to Hims & Hers (dated 2025-09-09, posted 2025-09-16; read November 20, 2026)